(Q34448102)

2 August 2017

title

The pharmacokinetics of intravenous and oral levodopa in patients with Parkinson's disease who exhibit on-off fluctuations (English)

1 reference

2 August 2017

0 references

1 reference

1 reference

1 reference

3

Lees AJ

1 reference

2 August 2017

Hardie RJ

1

1 reference

2 August 2017

Malcolm SL

series ordinal

2

1 reference

2 August 2017

Stern GM

series ordinal

4

1 reference

2 August 2017

Allen JG

series ordinal

5

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 October 1986

1 reference

British Journal of Clinical Pharmacology

2 August 2017

published in

1 reference

2 August 2017

volume

22

1 reference

2 August 2017

issue

4

1 reference

2 August 2017

page(s)

429-436

1 reference

The impact of treatment with levodopa on Parkinson's disease.

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401168

A comparison of the effects of reversible and irreversible inhibitors of aromatic L-amino acid decarboxylase on the half-life and other pharmacokinetic parameters of oral L-3,4-dihydroxyphenylalanine

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401168

Parkinsonism: onset, progression, and mortality

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401168

The metabolism of L-3-0-methyldopa, aprecursor of dopa in man

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401168

Variability of L-Dopa Absorption in Man

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401168

The effect of carbidopa on the pharmacokinetics of intravenously administered levodopa: the mechanism of action in the treatment of parkinsonism.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401168

3-0-Methyldopa uptake and inhibition of L-dopa at the blood-brain barrier

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401168

Protein Intake and Treatment of Parkinson's Disease with Levodopa

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401168

Levodopa pharmacokinetics. Alterations after benserazide, a decarboxylase inhibitor

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401168

Amino acid precursors of monoamine neurotransmitters and some factors influencing their supply to the brain

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1401168

The absorption and metabolism of a standard oral dose of levodopa in patients with Parkinsonism

6 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1986.TB02913.X

On-off fluctuations in Parkinson's disease. A clinical and neuropharmacological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1986.TB02913.X

Plasma dopa concentrations after different preparations of levodopa in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1986.TB02913.X

Active Transport of L-Dopa in the Intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.1986.TB02913.X

L-dopa level in plasma, primary condition for the kinetic effect

21 January 2018

1 reference

12 December 2020

Dosage form design for improvement of bioavailability of levodopa II: bioavailability of marketed levodopa preparations in dogs and parkinsonian patients

1 reference

12 December 2020

Gastric emptying rate and the systemic availability of levodopa in the elderly parkinsonian patient

1 reference

12 December 2020

Senile Parkinsonism and dopa pharmacokinetics

1 reference

12 December 2020

The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport

1 reference

12 December 2020

ELSMOS--an extended least squares modelling system in FORTRAN IV for mini- or micro-computer implementation

1 reference

12 December 2020

10.1111/J.1365-2125.1986.TB02913.X

Identifiers

DOI

1 reference

2 August 2017

1 reference

2 August 2017

1 reference